Multiple Myeloma, Newly Diagnosed Clinical Trials in Tianjin, Tianjin Municipality
2 recruitingTianjin, Tianjin Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT07106710
Recruiting
Phase 2
MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China60 enrolled1 locationNCT07106736